Latest News About Projectpuma

Updated 2026-05-21 04:01

I don’t have real-time access to the latest news right now. If you’d like, I can summarize what has been publicly reported about Project Puma from reliable sources up to my last update, or I can help you search for the most recent headlines if you authorize a web lookup.

Would you like me to:

If you want the latest, tell me to proceed with a web search and any specific angles you care about (e.g., product updates, regulatory milestones, leadership changes).

Sources

Press Release Distribution and Management

GlobeNewswire specializes in the distribution and delivery of press releases, financial disclosures and multimedia content to the media and general public.

www.globenewswire.com

About Puma Biotechnology

Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous), and PB357 in 2011. In 2022, Puma in-licensed global research and development and commercial rights to alisertib, a selective, small molecule, orally administered inhibitor of aurora kinase A. Neratinib is a...

www.pumabiotechnology.com

Puma | The Independent

The latest breaking news, comment and features from The Independent.

www.independent.co.uk

Pumas

Read the latest UK headlines, on NewsNow. UK news, analysis and opinion from around the world.

www.newsnow.co.uk